文献速递神经儿科影像MR

多次给予钆喷酸葡胺或钆特酸葡胺对儿童患者脑T1加权高信号影响的评估

Evaluation of the effect of multiple administrations of gadopentetate dimeglumine or gadoterate meglumine on brain T1-weighted hyperintensity in pediatric patients.
PubMed 文献 · Pediatr Radiol · 2021-07-20

回顾性队列研究纳入52例儿童(首次MRI年龄6.0个月至17.1岁),比较≥5次无混杂给药后线性钆喷酸葡胺与大环状钆特酸葡胺对脑T1-W信号强度的影响,发现钆喷酸葡胺组多个脑结构T1-W信号强度比值随时间显著变化,而钆特酸葡胺组仅1个位置出现变化。

要点

  • 儿童重复接受钆喷酸葡胺后多个脑结构T1-W信号强度比值随时间显著变化,钆特酸葡胺仅1个位置出现变化。
  • 钆喷酸葡胺组T1-W信号强度比值变化斜率存在个体差异的脑结构多于钆特酸葡胺组(14 vs. 8)。
  • 设备厂商、成像序列和场强对检测T1-W信号强度变化的能力有不同程度的系统性影响。

核心结论

  • 重复给予钆喷酸葡胺后多个脑结构T1-W信号强度比值随时间显著变化,而重复给予钆特酸葡胺后仅1个比值出现变化;两种对比剂重复给药后信号强度比值变化速率均存在个体差异。

研究设计与样本

  • 回顾性队列研究,纳入52例儿童患者(首次MRI年龄范围6.0个月至17.1岁),钆特酸葡胺组与钆喷酸葡胺组各26例,按无混杂钆基对比剂给药次数匹配;两名阅片者在脑内及周围27个结构绘制感兴趣区,采用线性混合效应模型评估钆基对比剂剂量数与T1-W信号强度比值的关系。

关键影像表现/征象

  • 钆特酸葡胺组在1个位置检测到重复给药后T1-W信号强度比值显著变化。
  • 钆喷酸葡胺组在4个位置检测到重复给药后T1-W信号强度比值显著变化。
  • 患者性别和年龄与T1-W信号强度变化无关联。
  • 设备厂商、成像序列和场强对检测T1-W信号强度变化的能力有不同程度的系统性差异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Repeated administrations of linear gadolinium-based contrast media (GBCM) are associated with T1-weighted (T1-W) signal intensity change in brain structures.

OBJECTIVE: The purpose of this study was to compare different brain structures in children after unconfounded, repeated administrations of either a macrocyclic or linear GBCM.

MATERIALS AND METHODS: We performed a retrospective cohort study, identifying subjects with ≥5 unconfounded administrations of gadoterate meglumine. We matched subjects with repeated administrations of gadopentetate dimeglumine to the gadoterate meglumine arm based on the number of unconfounded GBCM administrations. Two reviewers drew regions of interest on 27 structures in and around the brain. We recorded demographic, modality and study parameters and evaluated them to determine whether they were associated with T1-W signal intensity (SI) changes. Linear mixed effects models evaluated the relationships between the number of GBCM doses and T1-W SI ratio. Finally, we identified differences in the rate of T1-W SI ratio change among individuals using a linear mixed effects model with random slope.

RESULTS: We included a total of 52 patients (age range at first MRI: 6.0 months to 17.1 years), 26 in each arm. We detected a significant change in the T1-W SI ratio with repeated administrations of GBCM in one location in the gadoterate meglumine arm and in four locations in the gadopentetate dimeglumine arm. Patient gender and age were not associated with T1-W SI change. Modality vendor, imaging sequence and field strength were variably associated with a systematic difference in the ability to detect a T1-W SI change. Finally, linear mixed effects model with random slope showed that there were individual differences in the slope of SI change at various structures among individuals for both arms. This effect was present in more brain structures in the gadopentetate dimeglumine arm (14 vs. 8).

CONCLUSION: There is a significant change in the T1-W SI ratio over time in multiple brain structures after repeated gadopentetate dimeglumine administrations. This effect was only seen in one ratio after repeated administrations of gadoterate meglumine. There are individual differences in the rate of change of SI ratios over time after repeated administration of gadopentetate dimeglumine and gadoterate meglumine, suggesting that individual differences are present.

来源:Pediatr Radiol,查看原文。版权归原作者所有。

引用

  1. Towbin AJ, Zhang B, Dillman JR, et al. Evaluation of the effect of multiple administrations of gadopentetate dimeglumine or gadoterate meglumine on brain T1-weighted hyperintensity in pediatric patients. Pediatr Radiol. 2021. PMID: 34286351. doi:10.1007/s00247-021-05134-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。